136 related articles for article (PubMed ID: 20808985)
1. The value of different washout parameters in the evaluation of renal transplants by technetium-99m-ethylene- l-l-dicysteine.
Kanmaz B; Sayman HB; Alan N; Devranoglu G; Nisli S; Sonmezoglu K; Kabasakal L; Halac M; Onsel C; Uslu I
Hell J Nucl Med; 2010; 13(2):127-31. PubMed ID: 20808985
[TBL] [Abstract][Full Text] [Related]
2. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with
Afshan A; Sohaib M; Jehangir M
Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH.
Stoffel M; Jamar F; Van Nerom C; Verbruggen A; Mourad M; Leners N; Squifflet JP; Beckers C
J Nucl Med; 1994 Dec; 35(12):1951-8. PubMed ID: 7989976
[TBL] [Abstract][Full Text] [Related]
5. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
6. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans.
Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A
J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314
[TBL] [Abstract][Full Text] [Related]
7. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine.
Sohaib M; Rafique A; Saeed S; Afshan A
Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m ethylene dicysteine: a new renal tubular function agent.
Kabasakal L
Eur J Nucl Med; 2000 Mar; 27(3):351-7. PubMed ID: 10774890
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the renal dynamic scan performed with 99mTc-L,L-EC and 99mTc-MAG3 in children with pelviureteric junction obstruction.
Jain V; Arora S; Passah A; Mani K; Yadav DK; Goel P; Gupta DK
Nucl Med Commun; 2018 Nov; 39(11):1053-1058. PubMed ID: 30169343
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
11. Use of early postoperative MAG3 renal scan to predict long-term outcomes of renal transplants.
Park UJ; Kim HT; Cho WH; Kim MY; Hwang EA; Han SY; Park SB; Kim HC; Zeon SK
Exp Clin Transplant; 2013 Apr; 11(2):118-21. PubMed ID: 23477352
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-EC and other potential new agents in renal nuclear medicine.
Moran JK
Semin Nucl Med; 1999 Apr; 29(2):91-101. PubMed ID: 10321823
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure.
Prvulovich EM; Bomanji JB; Waddington WA; Rudrasingham P; Verbruggen AM; Ell PJ
J Nucl Med; 1997 May; 38(5):809-14. PubMed ID: 9170451
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of a single vial lyophilized preparation of technetium-99m labeled ethylene dicysteine as a renal scintigraphic agent.
Sohaib M; Afshan A; Saeed S; Khalid MA; Yousuf M
Pak J Pharm Sci; 2014 Sep; 27(5):1287-94. PubMed ID: 25176364
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of the four isomers of technetium-99m labeled ethylenecysteamine cysteine ((99m)Tc-ECC), the mono-acid derivative of (99m)tc-L,L-ethylenedicysteine.
Vanbilloen HP; Cleynhens BJ; Verbruggen AM
Nucl Med Biol; 2000 Feb; 27(2):207-14. PubMed ID: 10773551
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders.
Gupta NK; Bomanji JB; Waddington W; Lui D; Costa DC; Verbruggen AM; Ell PJ
Eur J Nucl Med; 1995 Jul; 22(7):617-24. PubMed ID: 7498222
[TBL] [Abstract][Full Text] [Related]
18. Parametric clearance kidney scintigrams; diagnostic potential in diabetes.
Frieske I; Surma MJ; Rogozińska-Zawiślak A; Szadkowska A; Gadzicki M; Bodalski J; Kuśmierek J
Nucl Med Rev Cent East Eur; 2007; 10(1):16-20. PubMed ID: 17694496
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-L,L-ethylenedicysteine is more effective than technetium-99m diethylenetriamine penta-acetic acid for excluding obstruction in patients with pyelocalicinal dilation.
Lima MC; de Lima ML; Pepe CF; Etchebehere EC; Santos AO; Amorim BJ; Camargo EE; Ferreira U; Palma PC; Ramos CD
Urology; 2010 Aug; 76(2):283-8. PubMed ID: 20206974
[TBL] [Abstract][Full Text] [Related]
20. Role of technetium-99m N,N-ethylenedicysteine renal scintigraphy in the evaluation of differential renal function and cortical defects.
Buyukdereli G; Guney IB
Clin Nucl Med; 2006 Mar; 31(3):134-8. PubMed ID: 16495730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
